People · Operator
Named in public records as an officer, director or promoter · active 2010–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aytu Bioscience, Inc | — | Pharmaceuticals | Series A | $28.8M | $309.7M | 2019 |
| Arbor Pharmaceuticals Inc | — | Pharmaceuticals | Series B | $22.0M | $592.2M | 2010 |
Jarrett Disbrow at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jarrett Disbrow on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Green | 1 | 8 |
| Todd Sone | 1 | 4 |
| Gregory A. Gould | 1 | 4 |
| Michael Macaluso | 1 | 4 |
| Steven Boyd | 1 | 3 |
| Edward Schutter | 1 | 3 |
| John Donofrio | 1 | 2 |
| Carl C. Dockery | 1 | 2 |
| Joshua R. Disbrow | 1 | 2 |
| Allen Chao | 1 | 2 |
| JOHN A. DONOFRIO JR. | 1 | 2 |
| Jason Wild | 1 | 2 |
| Ketan Mehta | 1 | 2 |
| Michael Fedida | 1 | 1 |
| Gary Cantrell | 1 | 1 |
| Carl Dockery | 1 | 1 |
| Josh Disbrow | 1 | 1 |
| Joshua Disbrow | 1 | 1 |
| John Donofrio Jr. | 1 | 1 |
| Gary V. Cantrell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.